| scholarly article | Q13442814 |
| P50 | author | Marcello Maggiolini | Q37841526 |
| Amalia Carpino | Q39718445 | ||
| Vincenzo Pezzi | Q57119424 | ||
| Rosa Sirianni | Q58895730 | ||
| P2093 | author name string | Adele Chimento | |
| Arianna De Luca | |||
| Fabiana Zolea | |||
| Sebastiano Andò | |||
| Vittoria Rago | |||
| P2860 | cites work | Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARgamma : Possible relevance to human fibrotic disorders | Q24538593 |
| The cyclooxygenases | Q24801433 | ||
| Celecoxib for the prevention of sporadic colorectal adenomas | Q28200368 | ||
| Estrogen and spermatogenesis | Q28201128 | ||
| Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor | Q28344632 | ||
| The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation | Q28587683 | ||
| Adaptive hypersensitivity following long-term estrogen deprivation: involvement of multiple signal pathways | Q30311955 | ||
| Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis | Q34060232 | ||
| Aromatase--a brief overview | Q34112633 | ||
| Prostanoid receptors: subtypes and signaling | Q34192781 | ||
| Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes | Q34203305 | ||
| Cyclooxygenase-2 upregulation as a perigenetic change in carcinogenesis. | Q34259811 | ||
| Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases | Q34589818 | ||
| Constitutive expression of prostaglandin-endoperoxide synthase 2 by somatic and spermatogenic cells is responsible for prostaglandin E2 production in the adult rat testis | Q34605958 | ||
| Potential Leydig cell mitogenic signals generated by the wild-type and constitutively active mutants of the lutropin/choriogonadotropin receptor (LHR). | Q35567393 | ||
| Multiple mechanisms control brain aromatase activity at the genomic and non-genomic level. | Q35586802 | ||
| Overexpression of aromatase leads to development of testicular leydig cell tumors : an in vivo model for hormone-mediated TesticularCancer | Q35793322 | ||
| PTGER1 and PTGER2 receptors mediate regulation of progesterone synthesis and type 1 11beta-hydroxysteroid dehydrogenase activity by prostaglandin E2 in human granulosa lutein cells | Q36088810 | ||
| Suppression of aromatase in human breast cells by a cyclooxygenase-2 inhibitor and its analog involves multiple mechanisms independent of cyclooxygenase-2 inhibition | Q36802784 | ||
| Prostaglandin endoperoxide synthase: structure and catalysis | Q37334573 | ||
| Testicular cancer: a review. | Q38561184 | ||
| Pathological Changes During Aging in, Barrier-Reared Fischer 344 Male Rats | Q39427676 | ||
| Hormonal regulation of androgen production by the Leydig cell | Q40141164 | ||
| Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells | Q40228364 | ||
| Involvement of protein kinase C and cyclic adenosine 3',5'-monophosphate-dependent kinase in steroidogenic acute regulatory protein expression and steroid biosynthesis in Leydig cells | Q40437876 | ||
| Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells. | Q40462696 | ||
| A steroidogenic factor-1-binding site and cyclic adenosine 3',5'-monophosphate response element-like elements are required for the activity of the rat aromatase promoter in rat Leydig tumor cell lines | Q40991904 | ||
| Expression of aromatase cytochrome P450 in rat H540 Leydig tumor cells | Q41068520 | ||
| Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis | Q41709477 | ||
| Differential expression of steroidogenic factor-1/adrenal 4 binding protein and liver receptor homolog-1 (LRH-1)/fetoprotein transcription factor in the rat testis: LRH-1 as a potential regulator of testicular aromatase expression | Q42455937 | ||
| Calcium-dependent phosphorylation processes control brain aromatase in quail | Q42599352 | ||
| Prostaglandin E2 increases growth and motility of colorectal carcinoma cells | Q43559615 | ||
| Pituitary adenylate cyclase-activating polypeptide induces testicular testosterone synthesis through PGE(2) mediation in crested newt, Triturus carnifex | Q44062927 | ||
| Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology | Q44174320 | ||
| Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature. | Q48793845 | ||
| Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients | Q48877598 | ||
| Expression of cyclooxygenase-1 and -2 in human colorectal cancer | Q53461597 | ||
| Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation. | Q53529918 | ||
| Estrogen and Spermatogenesis1 | Q55952854 | ||
| Detection of aromatase and estrogen receptors (ERα, ERβ1, ERβ2) in human Leydig cell tumor | Q60287193 | ||
| Cyclooxygenase-2 mRNA expression correlates with aromatase expression in human breast cancer | Q61857319 | ||
| Cyclooxygenases in rat Leydig cells: effects of luteinizing hormone and aging. | Q64977372 | ||
| 45 Assay of aromatase activity | Q67842856 | ||
| Role of the prostaglandin E2 receptor in mammary tumor metastasis | Q67914643 | ||
| Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue | Q70084992 | ||
| 6-Isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist | Q71598904 | ||
| Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene | Q71826297 | ||
| Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model | Q73081258 | ||
| Functional interactions, phosphorylation, and levels of 3',5'-cyclic adenosine monophosphate-regulatory element binding protein and steroidogenic factor-1 mediate hormone-regulated and constitutive expression of aromatase in gonadal cells | Q73127768 | ||
| Expression of cyclooxygenase-2 in human gastric carcinoma | Q73221180 | ||
| Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice | Q73693790 | ||
| Aberrant expression of aromatase in breast cancer tissues | Q73867503 | ||
| Cyclooxygenase-1 and -2 in human testicular tumours | Q73904955 | ||
| Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer | Q74376052 | ||
| Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation | Q74529917 | ||
| Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer | Q74592734 | ||
| Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas | Q77220353 | ||
| Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer | Q77601963 | ||
| SC-19220, a prostaglandin E2 antagonist, inhibits osteoclast formation by 1,25-dihydroxyvitamin D3 in cell cultures | Q77731485 | ||
| Cyclooxygenase-2 expression in human esophageal carcinoma | Q77804838 | ||
| Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens | Q77994194 | ||
| A randomized double-blind placebo-controlled phase II trial of the cyclooxygenase-2 inhibitor Celecoxib in the treatment of cervical dysplasia | Q83294102 | ||
| P433 | issue | 42 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 28905-28916 | |
| P577 | publication date | 2009-08-13 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of Leydig tumor cells | |
| P478 | volume | 284 |
| Q26851667 | Cyclooxygenase and prostaglandins in somatic cell populations of the testis |
| Q39701916 | Cyclooxygenase-2 and tissue inhibitor of matrix metalloproteinases-1 confer the antimigratory effect of cannabinoids on human trabecular meshwork cells |
| Q34514569 | Deletion of EP4 on Bone Marrow–Derived Cells Enhances Inflammation and Angiotensin II–Induced Abdominal Aortic Aneurysm Formation |
| Q40290479 | Downregulation of prostaglandin E2 is involved in hindgut mucosal damage in lactating goats fed a high-concentrate diet |
| Q42049244 | Elevated levels of the steroidogenic factor 1 are associated with over-expression of CYP19 in an oestrogen-producing testicular Leydig cell tumour |
| Q26865327 | GPER Signaling in Spermatogenesis and Testicular Tumors |
| Q36326358 | GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo |
| Q36099670 | Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women |
| Q53295839 | Mixtures of Uncaria and Tabebuia extracts are potentially chemopreventive in CBA/Ca mice: a long-term experiment. |
| Q39504547 | Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system. |
| Q36171080 | Overexpression of CYP19A1 aromatase in Leydig cells is associated with steroidogenic dysfunction in subjects with Sertoli cell-only syndrome. |
| Q28567192 | Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells |
| Q35733386 | Teasing out the role of aromatase in the healthy and diseased testis. |
Search more.